Tectonic Therapeutic director Timothy Springer buys $39.9 million in stock
Timothy A. Springer, a director and ten percent owner of Tectonic Therapeutic, Inc. (NASDAQ:TECX), has significantly increased his stake in the company through recent stock purchases. According to a ...
Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data
Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...
Tectonic secures $185 million in private equity funding
WATERTOWN, Mass. - Tectonic Therapeutic, Inc. (NASDAQ: TECX), a biotechnology company specializing in the development of therapeutic proteins and antibodies, announced today that it has entered into a ...
Tectonic Announces $185 Million Private Placement
Pursuant to the terms of the securities purchase agreement, at the closing of the PIPE, Tectonic will issue an aggregate of 3,689,465 shares of common stock at a price of $50.00 per share to fund ...
Tectonic Therapeutic announces $185M private placement
Tectonic Therapeutic (TECX) announced that it has entered into a securities purchase agreement for a private investment in public equity ...
GEN5d
StockWatch: Whirlwind Week for Nvidia as Investors Weigh DeepSeek’s Impact
What especially shook investors was the prospect that China may have closed the tech gap with the United States in AI and especially DeepSeek’s claim that it developed R1 for just $5.6 million—a far ...